IMAGE

Fig. 5

ID
ZDB-IMAGE-230915-13
Source
Figures for Wang et al., 2023
Image
Figure Caption

Fig. 5

Fig. 5. Thymosin mitigates vinorelbine-induced immunosuppression. (A) The transcription levels of immune-related factors after treatment of vinorelbine and thymosin for 18 h. The mRNA level of the model control group was set at 1 in the correlation analysis of qRT-PCR results. Data are expressed as mean ± SEM. n = 10. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001, ∗∗∗∗P < 0.0001 compared to the vinorelbine treatment group; #P < 0.05, ##P < 0.01, ###P < 0.001, ####P < 0.0001, comparison between the model control group and the vinorelbine treatment group. Abbreviations: T: thymosin; V: vinorelbine.

Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Biomed. Pharmacother.